Cellectis (CLLS) Other Working Capital Changes (2015 - 2026)
Cellectis' (CLLS) quarterly Other Working Capital Changes came in at $965000.0 in Q1 2026, up 14.47% year-on-year from $843000.0 in Q1 2025, and up 753.98% quarter-over-quarter from $113000.0 in Q4 2025.
Cellectis (CLLS) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Cellectis' Other Working Capital Changes history runs 13 years deep, the most recent figure standing at $965000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 14.47% year-over-year to $965000.0 in Q1 2026; TTM through Mar 2026 was $965000.0, a 14.47% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 162.35% from the prior year.
- Other Working Capital Changes grew to $965000.0 in Q1 2026 per CLLS's latest filing, from $113000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.5 million in Q1 2025 and bottomed at -$130.1 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is -$86000.0 (2022), against an average of -$25.0 million.
- Across the five-year window, Other Working Capital Changes soared 183.97% in 2023 and tumbled 268.8% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at $237000.0 in 2022, then surged by 183.97% to $673000.0 in 2023, then tumbled by 268.8% to -$1.1 million in 2024, then jumped by 109.95% to $113000.0 in 2025, then surged by 753.98% to $965000.0 in 2026.
- Per Business Quant, the three latest CLLS Other Working Capital Changes figures stand at $965000.0 (Q1 2026), $113000.0 (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.00 Mn |
| Mar 31, 2026 | -78.00 Mn |
| Mar 31, 2026 | -78.00 Mn |
| Sep 30, 2025 | -2.76 Mn |
| Sep 30, 2025 | -2.76 Mn |
| Sep 30, 2025 | -2.76 Mn |
| Jun 30, 2025 | -130.10 Mn |
| Jun 30, 2025 | -130.10 Mn |
| Jun 30, 2025 | -130.10 Mn |
| Mar 31, 2025 | 9.49 Mn |
| Mar 31, 2025 | 9.49 Mn |
| Mar 31, 2025 | 9.49 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | -105.39 Mn |
| Jun 30, 2024 | -105.39 Mn |
| Jun 30, 2024 | -105.39 Mn |
| Mar 31, 2024 | -1.69 Mn |
| Mar 31, 2024 | -1.69 Mn |